ReviewCancer treatment reviews2022

A comprehensive review on antibody-drug conjugates (ADCs) in the treatment landscape of non-small cell lung cancer (NSCLC).

Ziad Abuhelwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.